OmniAb (OABI) Net Margin (2022 - 2026)

OmniAb (OABI) reported Net Margin of 53.42% for Q1 2026, up 38471.0% year-over-year from N/an in Q1 2025, and up 68.44% quarter-over-quarter from 169.28% in Q4 2025.

OmniAb (OABI) Net Margin (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Net Margin data on file, last reported at 53.42% in Q1 2026.

  • Net Margin for Q1 2026 came in at 53.42%, up 38471.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 187.59% (up 4152.0% YoY), and the FY2025 annual result was 347.04%, down 11199.0% from the prior year.
  • Net Margin climbed to 53.42% in Q1 2026 per OABI's latest filing, from 169.28% in the prior quarter.
  • Over five years, Net Margin peaked at 19.3% in Q4 2022 and troughed at 738.05% in Q3 2025.
  • A 5-year average of 227.56% and a median of 179.03% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2024 and 2026: Net Margin slumped 46279 bps in 2024, then soared 38471 bps in 2026.
  • A 5-year view of Net Margin shows it stood at 19.3% in 2022, then slumped by 1610 bps to 291.44% in 2023, then jumped by 58 bps to 120.96% in 2024, then sank by 40 bps to 169.28% in 2025, then soared by 68 bps to 53.42% in 2026.
  • Business Quant data shows OABI's Net Margin at 53.42% in Q1 2026, 169.28% in Q4 2025, and 738.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn -53.42%

Historic Data

Download Data
DateValue
Mar 31, 2026 -53.42%
Dec 31, 2025 -169.28%
Sep 30, 2025 -738.05%
Jun 30, 2025 -407.36%
Mar 31, 2025 -438.13%
Dec 31, 2024 -120.96%
Sep 30, 2024 -392.45%
Jun 30, 2024 -179.03%
Mar 31, 2024 -498.84%
Dec 31, 2023 -291.44%
Sep 30, 2023 -287.35%
Jun 30, 2023 -212.04%
Mar 31, 2023 -36.05%
Dec 31, 2022 19.30%
Sep 30, 2022 -7.14%
Jun 30, 2022 -18.06%
Mar 31, 2022 -38.22%